![](https://s.hdnux.com/photos/01/40/51/70/25337351/5/rawImage.jpg)
CT-based Purdue Pharma gains FDA approval for overdose treatment
The FDA announced this week its approval of Stamford-based Purdue’s new drug application for Zurnai, the first nalmefene hydrochloride auto-injector for the emergency treatment of known or suspected opioid overdoses in adults and pediatric patients 12 …